BioNTech Says It Expects More Data on New Variant in 2 Weeks

FRANKFURT — BioNTech, the inventor of the western world’s most widely used COVID-19 vaccine, said it expects more laboratory data on a new worrying coronavirus variant detected in South Africa within two weeks to help determine whether the biotech firm’s shot would have to be reworked. Read More